Steadfast Capital Management’s Elevance Health ELV Stock Holding History

Steadfast Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-162,426	Closed	-$84.2M	–	61
2024 Q1	$84.2M	Sell	162,426 -94,058	-37%	-$46.8M	1.9%	21
2023 Q4	$121M	Sell	256,484 -22,516	-8%	-$10.4M	2.98%	14
2023 Q3	$121M	Buy	279,000 +25,700	+10%	+$11.7M	3.26%	12
2023 Q2	$113M	Buy	+253,300	New	+$117M	3%	14
2022 Q4	–	Sell	-135,442	Closed	-$61.5M	–	34
2022 Q3	$61.5M	Sell	135,442 -448,531	-77%	-$215M	1.66%	19
2022 Q2	$282M	Buy	583,973 +14,801	+3%	+$7.32M	6.2%	6
2022 Q1	$280M	Buy	569,172 +3,085	+0.5%	+$1.41M	4.8%	6
2021 Q4	$262M	Buy	566,087 +87,088	+18%	+$36.6M	4.38%	9
2021 Q3	$179M	Buy	+478,999	New	+$182M	1.73%	22

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Steadfast Capital Management's ELV Position: Q2 2024 in Review

Steadfast Capital Management sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 162,426 shares — an estimated $84.2M sold.

Steadfast Capital Management first reported a position in ELV in Q3 2021 and held it in 9 quarters. The position peaked at $282M in Q2 2022. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

Steadfast Capital Management reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
Steadfast Capital Management sold 162,426 Elevance Health shares in Q2 2024, an estimated $84.2M.
Steadfast Capital Management first reported a position in Elevance Health in Q3 2021 and held it in 9 quarters.
Steadfast Capital Management's Elevance Health position peaked at $282M in Q2 2022.
1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Steadfast Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.